Exercise and Fuel Metabolism
Exercise and Fuel Metabolism
批准号:
8447691
负责人:
DAVID H WASSERMAN
金额:
$5.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-01 至 2013-02-28
关键词:
5&apos-AMP-activated protein kinaseATP HydrolysisAcuteAddressAdenine NucleotidesAdoptedBlood GlucoseCatheterizationCellsChargeChronicConsciousCouplesDevelopmentDiabetes MellitusDietDyslipidemiasEffectivenessEpidemicExerciseFastingFatty acid glycerol estersFunctional disorderGeneticGenetic ModelsGlucagonGlucagon ReceptorGluconeogenesisGlucose Clamp TechniqueGrantHealthHealthcare SystemsHepaticHormonesInfusion proceduresInsulin ResistanceLife StyleLipidsLiverMetabolicMetabolic ControlMetabolic PathwayMetabolic syndromeMetabolismMethodsModelingModificationMusNon-Insulin-Dependent Diabetes MellitusNucleotidesObesityOperative Surgical ProceduresPathogenesisPhenotypePhosphoenolpyruvate CarboxylasePhysical activityPhysiologicalPhysiological AdaptationProceduresProtocols documentationQuality of lifeRegulationRiskRoleRunningSeveritiesShapesSignal TransductionSiteSymptomsTechniquesTestingTexasTissuesUniversitiesbaseblood glucose regulationdesignenergy balancefascinatefeedingimprovedin vivoindexingintrahepaticknockout geneliver metabolismmouse modeloxidationresearch studytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Metabolic syndrome is devastating our health care system and compromising the quality of life for millions. Understanding the pathogenesis of this condition is paramount to eliminating it. The metabolic syndrome is an epidemic because people have adopted a diet for which they are poorly adapted and a lifestyle that is largely inactive. Hepatic metabolic dysfunction associated with inadequate substrate oxidation, lipid accumulation, and dyslipidemia is a hallmark of metabolic syndrome as it is evident early in its development and is associated with the severity of other symptoms. It has been speculated that liver metabolic dysfunction is a causative step in the natural progression to metabolic syndrome. Despite the central role of liver metabolism to overall "metabolic health," the mechanism for its effectiveness in healthy physically active states, the factors responsible for dysfunction, and the means to correct dysfunction are poorly understood. The protocols that comprise this proposal are designed to define mechanisms that control (i) intra-hepatic energy balance during acute perturbations and (ii) intra-hepatic and whole body energy balance by modifications in diet and physical activity. The finding from the present grant cycle that shapes the aims of this proposal is based on an observation so fundamental to metabolism that it will influence flux control at the most basic level. What we have shown is that the energy state of the "healthy liver" undergoes dramatic deviations. Cellular energy status is tightly controlled in most tissues of the body, so that cells are in a highly charged state (low AMP:ATP). However, physiological conditions such as exercise and fasting can trigger a five- to tenfold increase in the AMP:ATP in liver. We will test whether (a) the increase in hepatic AMP:ATP during glucagon stimulation and exercise is due to ATP hydrolysis associated with the energetics of gluconeogenesis; (b) the nucleotide monophosphates signal the stimulation of hepatic substrate oxidation through the activation of AMPK11 and AMPK12 subunits; and (c) the hepatic adaptations to high fat feeding and physical activity are AMPK-dependent. The regulation of hepatic metabolism will be studied using surgical and experimental tools that allow well-controlled experiments to be carried out in vivo. Glucagon infusion, treadmill exercise, wheel running and high fat feeding will be used as tools to amplify physiological signals and as a means of perturbing hepatic metabolic control. Mechanisms of action and sites of dysfunction will be delineated using well-defined genetic mouse models. Hepatic substrate metabolism will be quantified using sophisticated isotopic approaches employing 2H and 13C NMR analytical techniques. These studies will define how liver substrate fluxes are regulated in the healthy liver and where sites of dysfunction lie in the pathogenesis of metabolic syndrome and hepatic insulin resistance. PUBLIC HEALTH RELEVANCE. Metabolic syndrome and Type II diabetes are an enormous burden on our health care system. The physiological adaptations to exercise decrease the risk of developing these conditions, at least in part by improving liver metabolic function. The aim of this proposal is to elucidate the mechanism by which exercise improves metabolic regulation by the liver.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative
-
批准号:10588960
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2023
-
负责人:DAVID H WASSERMAN
-
依托单位:
Vanderbilt Center for Metabolic Phenotyping in Live Models of Obesity and Diabetes
-
批准号:10588959
-
项目类别:
-
资助金额:$76.64万
-
财政年份:2023
-
负责人:DAVID H WASSERMAN
-
依托单位:
Mouse Exercise and Metabolic Phenotyping Core
-
批准号:10242069
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2019
-
负责人:DAVID H WASSERMAN
-
依托单位:
Mouse Exercise and Metabolic Phenotyping Core
-
批准号:10468246
-
项目类别:
-
资助金额:$22.52万
-
财政年份:2019
-
负责人:DAVID H WASSERMAN
-
依托单位:
Mouse Exercise and Metabolic Phenotyping Core
-
批准号:10677757
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2019
-
负责人:DAVID H WASSERMAN
-
依托单位:
Mouse Exercise and Metabolic Phenotyping Core
-
批准号:10018900
-
项目类别:
-
资助金额:$23.11万
-
财政年份:2019
-
负责人:DAVID H WASSERMAN
-
依托单位:
Exercise and Fuel Metabolism
-
批准号:8006764
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2010
-
负责人:DAVID H WASSERMAN
-
依托单位:
Vanderbilt Mouse Metabolic Phenotyping Center
-
批准号:7930013
-
项目类别:
-
资助金额:$52.76万
-
财政年份:2009
-
负责人:DAVID H WASSERMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7638637
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2008
-
负责人:DAVID H WASSERMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7560711
-
项目类别:
-
资助金额:$16.91万
-
财政年份:2007
-
负责人:DAVID H WASSERMAN
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7662149
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2006
-
负责人:DAVID H WASSERMAN
-
依托单位:
ANALYTICAL CORE
-
批准号:7662152
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2006
-
负责人:DAVID H WASSERMAN
-
依托单位:
ANIMAL HEALTH CORE
-
批准号:7662155
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2006
-
负责人:DAVID H WASSERMAN
-
依托单位:
METABOLIC CORE
-
批准号:7662150
-
项目类别:
-
资助金额:$27.97万
-
财政年份:2006
-
负责人:DAVID H WASSERMAN
-
依托单位:
CARDIOVASCULAR CORE
-
批准号:7662151
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2006
-
负责人:DAVID H WASSERMAN
-
依托单位:
Murine GI Surgical Modeling Core
-
批准号:8665899
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2002
-
负责人:DAVID H WASSERMAN
-
依托单位:
Murine GI Surgical Modeling Core
-
批准号:8450725
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2002
-
负责人:DAVID H WASSERMAN
-
依托单位:
Murine GI Surgical Modeling Core
-
批准号:8893057
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2002
-
负责人:DAVID H WASSERMAN
-
依托单位:
Murine GI Surgical Modeling Core
-
批准号:8341156
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2002
-
负责人:DAVID H WASSERMAN
-
依托单位:
Vanderbilt Mouse Metabolic Phenotyping Center
-
批准号:9173317
-
项目类别:
-
资助金额:$110.49万
-
财政年份:2001
-
负责人:DAVID H WASSERMAN
-
依托单位:
海外基金